Global Radioimmunoassay Market Overview:
Global Radioimmunoassay Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Radioimmunoassay Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Radioimmunoassay involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Radioimmunoassay Market:
The Radioimmunoassay Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Radioimmunoassay Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Radioimmunoassay Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Radioimmunoassay market has been segmented into:
Immunoradiometric Assay
Radiobinding Assay
Radioreceptor Assay
By Application, Radioimmunoassay market has been segmented into:
Oncology
Infectious Disease
Endocrinology
Immunology
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Radioimmunoassay market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Radioimmunoassay market.
Top Key Players Covered in Radioimmunoassay market are:
Abbott Laboratories
QuidelOrtho Corporation
HoffmannLa Roche Ltd.
Ortho Clinical Diagnostics
Becton
Dickinson and Company
Thermo Fisher Scientific Inc.
EKF Diagnostics Holdings plc
Beckman Coulter
Inc.
Danaher Corporation
PerkinElmer Inc.
BioRad Laboratories
Inc.
Agilent Technologies
Inc.
Siemens Healthineers
DiaSorin S.p.A.
Sysmex Corporation
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Radioimmunoassay Market Type
4.1 Radioimmunoassay Market Snapshot and Growth Engine
4.2 Radioimmunoassay Market Overview
4.3 Immunoradiometric Assay
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Immunoradiometric Assay: Geographic Segmentation Analysis
4.4 Radiobinding Assay
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Radiobinding Assay: Geographic Segmentation Analysis
4.5 Radioreceptor Assay
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Radioreceptor Assay: Geographic Segmentation Analysis
Chapter 5: Radioimmunoassay Market Application
5.1 Radioimmunoassay Market Snapshot and Growth Engine
5.2 Radioimmunoassay Market Overview
5.3 Oncology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Oncology: Geographic Segmentation Analysis
5.4 Infectious Disease
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Infectious Disease: Geographic Segmentation Analysis
5.5 Endocrinology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Endocrinology: Geographic Segmentation Analysis
5.6 Immunology
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Immunology: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Radioimmunoassay Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 QUIDELORTHO CORPORATION
6.4 HOFFMANNLA ROCHE LTD.
6.5 ORTHO CLINICAL DIAGNOSTICS
6.6 BECTON
6.7 DICKINSON AND COMPANY
6.8 THERMO FISHER SCIENTIFIC INC.
6.9 EKF DIAGNOSTICS HOLDINGS PLC
6.10 BECKMAN COULTER
6.11 INC.
6.12 DANAHER CORPORATION
6.13 PERKINELMER INC.
6.14 BIORAD LABORATORIES
6.15 INC.
6.16 AGILENT TECHNOLOGIES
6.17 INC.
6.18 SIEMENS HEALTHINEERS
6.19 DIASORIN S.P.A.
6.20 SYSMEX CORPORATION
Chapter 7: Global Radioimmunoassay Market By Region
7.1 Overview
7.2. North America Radioimmunoassay Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Immunoradiometric Assay
7.2.2.2 Radiobinding Assay
7.2.2.3 Radioreceptor Assay
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Oncology
7.2.3.2 Infectious Disease
7.2.3.3 Endocrinology
7.2.3.4 Immunology
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Radioimmunoassay Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Immunoradiometric Assay
7.3.2.2 Radiobinding Assay
7.3.2.3 Radioreceptor Assay
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Oncology
7.3.3.2 Infectious Disease
7.3.3.3 Endocrinology
7.3.3.4 Immunology
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Radioimmunoassay Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Immunoradiometric Assay
7.4.2.2 Radiobinding Assay
7.4.2.3 Radioreceptor Assay
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Oncology
7.4.3.2 Infectious Disease
7.4.3.3 Endocrinology
7.4.3.4 Immunology
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Radioimmunoassay Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Immunoradiometric Assay
7.5.2.2 Radiobinding Assay
7.5.2.3 Radioreceptor Assay
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Oncology
7.5.3.2 Infectious Disease
7.5.3.3 Endocrinology
7.5.3.4 Immunology
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Radioimmunoassay Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Immunoradiometric Assay
7.6.2.2 Radiobinding Assay
7.6.2.3 Radioreceptor Assay
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Oncology
7.6.3.2 Infectious Disease
7.6.3.3 Endocrinology
7.6.3.4 Immunology
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Radioimmunoassay Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Immunoradiometric Assay
7.7.2.2 Radiobinding Assay
7.7.2.3 Radioreceptor Assay
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Oncology
7.7.3.2 Infectious Disease
7.7.3.3 Endocrinology
7.7.3.4 Immunology
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Radioimmunoassay Scope:
|
Report Data
|
Radioimmunoassay Market
|
|
Radioimmunoassay Market Size in 2025
|
USD XX million
|
|
Radioimmunoassay CAGR 2025 - 2032
|
XX%
|
|
Radioimmunoassay Base Year
|
2024
|
|
Radioimmunoassay Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, QuidelOrtho Corporation, HoffmannLa Roche Ltd., Ortho Clinical Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., EKF Diagnostics Holdings plc, Beckman Coulter, Inc., Danaher Corporation, PerkinElmer Inc., BioRad Laboratories, Inc., Agilent Technologies, Inc., Siemens Healthineers, DiaSorin S.p.A., Sysmex Corporation.
|
|
Key Segments
|
By Type
Immunoradiometric Assay
Radiobinding Assay
Radioreceptor Assay
By Applications
Oncology
Infectious Disease
Endocrinology
Immunology
|
